IGMS
IGM Biosciences
IGMS
IGMS
Delisted
IGMS was delisted on the 13th of August, 2025.
74 hedge funds and large institutions have $245M invested in IGM Biosciences in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 28 increasing their positions, 26 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
20% less capital invested
Capital invested by funds: $305M → $245M (-$59.6M)
53% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 15
Holders
74
Holding in Top 10
–
Calls
$912K
Puts
$83K
Top Buyers
| 1 | +$2.67M | |
| 2 | +$2.12M | |
| 3 | +$1.78M | |
| 4 |
AG
Artal Group
Luxembourg
|
+$824K |
| 5 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
+$766K |
Top Sellers
| 1 | -$3.8M | |
| 2 | -$1.67M | |
| 3 | -$1.53M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.18M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$922K |